ESMO 2016 not only reflected the increasing interest in oncology by attracting close to 20.000 participants, but also featured the presentation of several important abstracts that may lead to changes in the daily clinical management of gynaecological cancers. This was especially the case for ovarian carcinomas.

(BELG J MED ONCOL 2016;10(8):301–07)